SNHG6 and breast cancer: While our present report is the first one to demonstrate sponging of miR-101 by SNHG6 in breast cancer, particularly in tamoxifen-resistant breast cancer, there is ample evidence from other cancer as well as non-cancer models to confirm such miR-101 sponging by SNHG6.